SYNLOGIC, INC. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
SYNLOGIC, INC. (SYBX) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2026-08-11
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2025 was $81.00K, a 93.02% decline from fiscal 2024.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2024 was $1.16M, a 10445.45% increase from fiscal 2023.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2023 was $11.00K.
- SYNLOGIC, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was $0.00.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $69.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $69.00K derived: sum of 3 quarters · filed 2026-08-11 | $81.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $69.00K derived: sum of 2 quarters · filed 2026-08-11 | $81.00K 10-Q · filed 2025-11-13 | $83.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $81.00K 10-Q · filed 2026-08-11 | $83.00K derived: sum of 3 quarters · filed 2026-08-11 | $94.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-14 | $14.00K derived: sum of 2 quarters · filed 2026-05-14 | $25.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.07M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $13.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.06M derived: sum of 3 quarters · filed 2026-03-12 | $1.16M 10-K · filed 2026-03-12 |
| 2024-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.05M derived: sum of 2 quarters · filed 2025-11-13 | $1.16M 10-Q · filed 2025-11-13 | $1.16M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.15M 10-Q · filed 2025-08-07 | $1.15M derived: sum of 3 quarters · filed 2025-08-07 | $1.15M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $103.00K 10-Q · filed 2025-05-08 | $103.00K derived: sum of 2 quarters · filed 2025-05-08 | $103.00K derived: sum of 3 quarters · filed 2025-05-08 | $103.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $11.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $11.00K 10-Q · filed 2024-11-12 | $11.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $11.00K 10-Q · filed 2024-08-08 | $11.00K derived: sum of 3 quarters · filed 2024-08-08 | $11.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $11.00K 10-Q · filed 2024-05-14 | $11.00K derived: sum of 2 quarters · filed 2024-05-14 | $11.00K derived: sum of 3 quarters · filed 2024-05-14 | $11.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | $0.00 10-K · filed 2024-03-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |